Carl Walkey - 19 May 2021 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NGNE)

Role
Senior Vice President
Signature
/s/ Kris McGrew, as Attorney-in-Fact for Carl Walkey
Issuer symbol
NGNE
Transactions as of
19 May 2021
Net transactions value
-$6,378
Form type
4
Filing time
21 May 2021, 17:24:45 UTC
Previous filing
12 May 2021
Next filing
26 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NLTX Common Stock Sale $6,378 -600 -0.04% $10.63* 1,355,539 19 May 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2 Includes 1,377 shares of Common Stock acquired on May 14, 2021 pursuant to the Issuer's employee stock purchase plan.